GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cryo-Cell International Inc (AMEX:CCEL) » Definitions » Inventory-to-Revenue

Cryo-Cell International (Cryo-Cell International) Inventory-to-Revenue : 0.10 (As of Feb. 2024)


View and export this data going back to . Start your Free Trial

What is Cryo-Cell International Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cryo-Cell International's Average Total Inventories for the quarter that ended in Feb. 2024 was $0.76 Mil. Cryo-Cell International's Revenue for the three months ended in Feb. 2024 was $7.85 Mil. Cryo-Cell International's Inventory-to-Revenue for the quarter that ended in Feb. 2024 was 0.10.

Cryo-Cell International's Inventory-to-Revenue for the quarter that ended in Feb. 2024 declined from Nov. 2023 (0.12) to Nov. 2023 (0.10)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cryo-Cell International's Days Inventory for the three months ended in Feb. 2024 was 32.19.

Inventory Turnover measures how fast the company turns over its inventory within a year. Cryo-Cell International's Inventory Turnover for the quarter that ended in Feb. 2024 was 2.83.


Cryo-Cell International Inventory-to-Revenue Historical Data

The historical data trend for Cryo-Cell International's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryo-Cell International Inventory-to-Revenue Chart

Cryo-Cell International Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Inventory-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.03 0.03 0.03 0.03

Cryo-Cell International Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.11 0.12 0.12 0.10

Competitive Comparison of Cryo-Cell International's Inventory-to-Revenue

For the Medical Care Facilities subindustry, Cryo-Cell International's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryo-Cell International's Inventory-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cryo-Cell International's Inventory-to-Revenue falls into.



Cryo-Cell International Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cryo-Cell International's Inventory-to-Revenue for the fiscal year that ended in Nov. 2023 is calculated as

Inventory-to-Revenue (A: Nov. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Nov. 2022 ) + Total Inventories (A: Nov. 2023 )) / count ) / Revenue (A: Nov. 2023 )
=( (0.851 + 0.769) / 2 ) / 31.344
=0.81 / 31.344
=0.03

Cryo-Cell International's Inventory-to-Revenue for the quarter that ended in Feb. 2024 is calculated as

Inventory-to-Revenue (Q: Feb. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Nov. 2023 ) + Total Inventories (Q: Feb. 2024 )) / count ) / Revenue (Q: Feb. 2024 )
=( (0.769 + 0.755) / 2 ) / 7.852
=0.762 / 7.852
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cryo-Cell International  (AMEX:CCEL) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cryo-Cell International's Days Inventory for the three months ended in Feb. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Feb. 2024 )/Cost of Goods Sold (Q: Feb. 2024 )*Days in Period
=0.762/2.16*365 / 4
=32.19

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cryo-Cell International's Inventory Turnover for the quarter that ended in Feb. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Feb. 2024 ) / Average Total Inventories (Q: Feb. 2024 )
=2.16 / 0.762
=2.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cryo-Cell International Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cryo-Cell International's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryo-Cell International (Cryo-Cell International) Business Description

Traded in Other Exchanges
Address
700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
Executives
David Portnoy director, officer: Co-Chief Executive Officer C/O FOCUS FINANCIAL GROUP, 61 HARBOUR WAY, BAL HARBOUR FL 33154
George Gaines director 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Jonathan H. Wheeler director 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Brian L. Sheehy director 415 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10017
Mark L. Portnoy director, officer: Co-Chief Executive Officer 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Harold D. Berger director 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Arthur Ellis director 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Mary J Nyberg 10 percent owner 455 E MAYO BLVD, UNIT 5202, PHOENIX AZ 85050
Cdmj Nyberg Family Trust 10 percent owner 455 E MAYO BLVD, UNIT 5202, PHOENIX AZ 85050
Jill M Taymans officer: VP, Finance, CFO
Oleg Mikulinsky officer: Chief Information Officer 700 BROOKER CREEK BLVD., SUITE 1800, OLDSMAR FL 34677
Anthony Atala director 700 BROOKER CREEK BOULEVARD, OLDSMAR FL 34677
Scott G Christian director
Sung Won Sohn director 700 BROOKER CREEK BLVD., SUITE 1800, OLDSMAR FL 34677
Michael W. Cho director C/O IOWA STATE UNIVERSITY, 1600 S. 16TH STREET, AMES IA 50011-1250